Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.

Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.

The health system, meanwhile, said it stands by its decision to terminate the interventional cardiologist after working with him for several years. 

Florida-based Cardiovascular Associates of America has expanded its roster to include a team of 14 cardiologists and advanced practitioners in Arizona. 

Foluso Fakorede, MD, an interventional cardiologist with Cardiovascular Solutions of Central Mississippi, says these issues are typically overlooked in today's healthcare environment. 

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

Physician payments are down slightly across the board, but they've fallen significantly for a handful of specialties. Researchers examined the long-term impact this trend could have on patient care.

The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving.